EMEA-002708-PIP02-21
Key facts
Active substance |
Verdiperstat
|
Therapeutic area |
Neurology
|
Decision number |
P/0523/2021
|
PIP number |
EMEA-002708-PIP02-21
|
Pharmaceutical form(s) |
Modified-release tablet
|
Condition(s) / indication(s) |
Treatment of amyotrophic lateral sclerosis
|
Route(s) of administration |
Oral use
|
Contact for public enquiries |
Biohaven Pharmaceutical Ireland DAC
Email: medinfo@biohavenpharma.com |
Decision type |
W: decision granting a waiver in all age groups for all conditions or indications
|